Reorganization of GI Protection in China

China’s administrative system for IP protection is currently in the state of reorganization and consolidation into one head organization, CNIPA (China National IP Administration). This means certain delays in processing of particular IP issues – e.g., awarding the status of Famous Trademark has been factually postponed for nearly a year now. Another area that is… Continue reading Reorganization of GI Protection in China

Stricter Control of Experimental Data in China

In the field of pharmaceutical and chemical substances, inconsistencies in the experimental data of a patent application in China can lead to the doubts on patent’s validity. The Higher People’s Court in Peking has decided in multiple cases that submission of incomplete or false data violates the “quid pro quo” principle in disclosing the patent… Continue reading Stricter Control of Experimental Data in China

Great Wall of Consequences

China once again tightens the measures against IP rights infringers and strengthens own control over companies and managers. 38 Chinese state-level authorities signed a Memorandum of Understanding (MOU) on December 5, 2018. Central message of the document is that authorities – including the National Intellectual Property Administration and the Supreme People’s Court – are working… Continue reading Great Wall of Consequences

China and EU: First Steps in Harmonization of IP Protection

The new China National Intellectual Property Administration (CNIPA) and the European Patent Office (EPO) set plans for their future cooperation in Munich on September 21, 2018. It was the first meeting of CNIPA and EPO since the Chinese trademark and patent administration merged into a single administration in August (link to the article). CNIPA is,… Continue reading China and EU: First Steps in Harmonization of IP Protection